Association Between Hypertension and New-Onset Non-Alcoholic Fatty Liver Disease in Chinese Non-Obese People: A Longitudinal Cohort Study

被引:4
|
作者
Yang, Dezhi [1 ]
Lan, Jing [2 ]
Cen, Ji [3 ]
Han, Yong [4 ,5 ,6 ,9 ]
Hu, Haofei [6 ,7 ,8 ,10 ]
机构
[1] Hechi Peoples Hosp, Dept Cardiol Ward 2, Hechi, Peoples R China
[2] Hechi Peoples Hosp, Dept Gastroenterol, Hechi, Peoples R China
[3] Hechi Peoples Hosp, Dept Nephrol, Hechi, Peoples R China
[4] Shenzhen Second Peoples Hosp, Dept Emergency, Shenzhen, Peoples R China
[5] Shenzhen Univ, Dept Emergency, Affiliated Hosp 1, Shenzhen, Peoples R China
[6] Shenzhen Univ, Hlth Sci Ctr, Shenzhen, Peoples R China
[7] Shenzhen Second Peoples Hosp, Dept Nephrol, Shenzhen, Peoples R China
[8] Shenzhen Univ, Dept Nephrol, Affiliated Hosp 1, Shenzhen, Peoples R China
[9] Shenzhen Second Peoples Hosp, Dept Emergency, 3002 Sungang Rd, Shenzhen, Guangdong, Peoples R China
[10] Shenzhen Second Peoples Hosp, Dept Nephrol, 3002 Sungang Rd, Shenzhen, Guangdong, Peoples R China
来源
DIABETES METABOLIC SYNDROME AND OBESITY | 2023年 / 16卷
关键词
hypertension; non-alcoholic fatty liver disease; propensity-score matching; standardized-mortality-ratio weights; inverse probability of treatment weights; MARGINAL STRUCTURAL MODELS; AMBULATORY BLOOD-PRESSURE; INSULIN-RESISTANCE; PROPENSITY SCORE; GLOBAL EPIDEMIOLOGY; PREVALENCE; MANAGEMENT; DIAGNOSIS; BIAS; STRATEGIES;
D O I
10.2147/DMSO.S396011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Quantification of the relationship between hypertension and non-alcoholic fatty liver disease (NAFLD) risk is limited and controversial. This study aimed to investigate the relationship between hypertension and NAFLD in non-obese Chinese and to use different methods to demonstrate that hypertension is an independent risk factor for NAFLD.Methods: On 16,153 nonobese individuals, a retrospective cohort study was conducted in China to examine the impact of hypertension on incident NAFLD. We compared five methods: multivariable Cox proportional-hazards regression, propensity score -matched (PSM) analysis, propensity score adjustment method (considering the propensity score as a covariate in a multivariable Cox proportional-hazard regression), and two propensity score-based weighted methods-The first one estimated the hypertension effect in the overall study population-inverse probability of treatment weights (IPTW), the other in the hypertensive population-standardized mortality ratio (SMR) weights. We also used a genetic matching (GenMatch) algorithm to match the participants for sensitive analysis.Results: Between 2010 and 2014, 16,153 participants met our inclusion criteria, including 2427 (15.03%) with hypertension. A total of 2321 (14.37%) participants developed NAFLD during the median follow-up of 2.98 years. The crude hazard ratio (HR) between hypertension and incident NAFLD was 2.05 (95% confidence interval (CI): 1.87, 2.25). The adjusted HR depended on the different methods, ranging from 1.09 (95% CI: 0.77, 1.23) for the PSM method to 2.24 (95% CI: 2.05, 2.44) for the SMR weighted analysis. Hypertensive participants with high propensity scores had a higher risk of developing NAFLD in the future. Excluding participants with propensity scores <8% yielded comparable hazard ratios with a narrower range, from 1.04 to 1.80. After adjusting for the confounding variables, the relationship also existed in the GenMatch cohort as a sensitivity analysis (HR=1.06, 95% CI 1.01-1.13). Conclusion: Hypertension is a significant cause of NAFLD in Chinese adults in non-obese Chinese adults, with the hazard ratio ranging from 1.09 to 2.24.
引用
收藏
页码:345 / 363
页数:19
相关论文
共 50 条
  • [1] Association between the ZJU index and risk of new-onset non-alcoholic fatty liver disease in non-obese participants: a Chinese longitudinal prospective cohort study
    Zheng, Keyang
    Yin, Yuzhe
    Guo, Hang
    Ma, Linlin
    Liu, Rufei
    Zhao, Tianzhu
    Wei, Yuxuan
    Zhao, Zixu
    Cheng, Wenli
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [2] Association between the atherogenic index of plasma and new-onset non-alcoholic fatty liver disease in non-obese participants
    Li, Kemin
    Li, Ji
    Cheng, Xiaoyun
    Wang, Jing
    Li, Jingnan
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [3] Evaluated Glomerular Filtration Rate Is Associated With Non-alcoholic Fatty Liver Disease: A 5-Year Longitudinal Cohort Study in Chinese Non-obese People
    Cen, Ji
    Han, Yong
    Liu, Yufei
    Hu, Haofei
    FRONTIERS IN NUTRITION, 2022, 9
  • [4] Association between the alanine aminotransferase/aspartate aminotransferase ratio and new-onset non-alcoholic fatty liver disease in a nonobese Chinese population: a population-based longitudinal study
    Zou, Yang
    Zhong, Ling
    Hu, Chong
    Sheng, Guotai
    LIPIDS IN HEALTH AND DISEASE, 2020, 19 (01)
  • [5] Association Between Serum Uric Acid and Non-alcoholic Fatty Liver Disease in Non-obese Young Population: A Prospective Cohort Study
    Li, Yunpeng
    Ma, Xiangming
    Cui, Shuqing
    Jiang, Guochao
    Jia, Jianguo
    Ge, Xinyu
    Cao, Liying
    DIGESTIVE DISEASES AND SCIENCES, 2025, 70 (02) : 825 - 834
  • [6] A significant association of non-obese non-alcoholic fatty liver disease with sarcopenic obesity
    Kashiwagi, Kazuhiro
    Takayama, Michiyo
    Fukuhara, Kayoko
    Shimizu-Hirota, Ryoko
    Chu, Po-Sung
    Nakamoto, Nobuhiro
    Inoue, Nagamu
    Iwao, Yasushi
    Kanai, Takanori
    CLINICAL NUTRITION ESPEN, 2020, 38 : 86 - 93
  • [7] The Risk of Type 2 Diabetes and Coronary Artery Disease in Non-obese Patients With Non-alcoholic Fatty Liver Disease: A Cohort Study
    Dai, Wen
    Zhang, Ziyu
    Zhao, Shuiping
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [8] Overview of the Association Between Non-Alcoholic Fatty Liver Disease and Hypertension
    Kakouri, Niki S.
    Thomopoulos, Costas G.
    Siafi, Eirini P.
    Valatsou, Angeliki E.
    Dimitriadis, Kyriakos S.
    Mani, Iliana P.
    Patsilinakos, Sotirios P.
    Tousoulis, Dimitrios M.
    Tsioufis, Konstantinos P.
    CARDIOLOGY DISCOVERY, 2024, 4 (01): : 30 - 37
  • [9] Non-alcoholic Fatty Liver Disease in Non-obese Patients
    Christopher J. Schmoyer
    Mohammad S. Siddiqui
    Current Hepatology Reports, 2017, 16 (4) : 382 - 390
  • [10] Non-alcoholic fatty liver disease in non-obese children COMMENT
    Zdanowicz, Katarzyna
    Bialokoz-Kalinowska, Irena
    Lebensztejn, Dariusz M.
    HONG KONG MEDICAL JOURNAL, 2020, 26 (05) : 459 - 462